Join the Evzio group to help and get support from people like you.
Evzio News
More Than Half Do Not Know Primary Care Providers Can Treat Opioid Use Disorder
FRIDAY, July 12, 2024 – Many people do not know that a primary care provider (PCP) can provide medication for opioid use disorder (MOUD), according to a research letter published online June 28...
Trained Peers as Good as Social Workers at Preventing Opioid Overdoses
THURSDAY, July 11, 2024 – Support provided by someone who has personally lived with addiction is an effective way to follow-up with ER patients after an opioid overdose, new research shows. Patients...
New Drug Could Boost Lifesaving Powers of Overdose Drug Naloxone
MONDAY, July 8, 2024 – An experimental drug can supercharge the effects of the lifesaving overdose drug naloxone, potentially improving its effectiveness against new and more powerful opioids like...
Most Americans Don't Know That Family Doctors Can Prescribe Anti-Opioid Meds
TUESDAY, July 2, 2024 – Most people addicted to opioids and their loved ones are unaware that their primary care doctor can prescribe a medication to treat the disorder, a new nationwide survey...
Most Outpatient Mental Health Clinics Don't Offer Opioid Addiction Meds
WEDNESDAY, June 19, 2024 – Only a third of outpatient mental health facilities offer medications essential for treating opioid addiction, a new study finds. Standard care for treating people with...
High Out-of-Pocket Costs Keep Some From Lifesaving Opioid Antidote
TUESDAY, June 18, 2024 – Patients are less likely to fill prescriptions for the overdose-reversing drug naloxone when they have to shell out more at the pharmacy, a new study finds. Naloxone (also...
Racial Disparity Seen in Naloxone Administration
FRIDAY, May 31, 2024 – In Pennsylvania, from 2019 to 2021, Black people who died from overdose deaths had lower odds of naloxone administration compared with White and Hispanic people, according to...
Few Young Adults Could Administer Naloxone to Reverse Fentanyl Overdose
MONDAY, April 22, 2024 – Even though fentanyl-linked fatal overdoses are soaring among young adults, a new survey of American college students found that just 1 in 7 knew how to administer the...
Biden Administration Calls for Greater Access to Overdose Antidote
WEDNESDAY, March 13, 2024 – The White House on Wednesday launched a nationwide call for more training and better access to the lifesaving opioid overdose drug naloxone. Called the Challenge to Save...
Biden Administration Urges Schools to Carry Naloxone
TUESDAY, Oct. 31, 2023 – The Biden administration is encouraging schools throughout the United States to carry naloxone (Narcan) to help prevent fatal drug overdoses in students. The medication was...
Biden Administration Urges Schools to Carry Naloxone, the Opioid Overdose Treatment
TUESDAY, Oct. 31, 2023 – The Biden administration is encouraging schools throughout the United States to carry naloxone to help prevent fatal drug overdoses in students. The medication (Narcan) was...
Two-Thirds of Americans Say Their Lives Have Been Affected by Addiction: Poll
TUESDAY, Aug. 15, 2023 – Millions of Americans are addicted to drugs or alcohol, and millions more struggle with an addicted family member or friend, a new poll finds. Two-thirds of those surveyed...
Just 1 in 5 Americans Struggling With Opioid Misuse Gets Meds That Can Help
MONDAY, Aug. 7, 2023 – The U.S. opioid abuse epidemic wages on, and overdose deaths continue to rise, yet just 1 in 5 people receives potentially lifesaving medication such as methadone,...
FDA Approves Second OTC Naloxone Spray, ReVive, for Suspected Opioid Overdose
THURSDAY, Aug. 3, 2023 – The U.S. Food and Drug Administration has approved RiVive, an over-the-counter (OTC) naloxone hydrochloride nasal spray for emergency treatment of known or suspected opioid...
Monthly News Roundup - July 2023
FDA Clears Opill, the First Over-the-Counter (OTC) Oral Birth Control Pill History in women’s health was made in July when the FDA cleared Opill (norgestrel 0.075 mg), the first over-the-counter (...
Ask a question
To post your own question to this support group, sign in or create an account.